Literature DB >> 2255000

Effect of immunosuppressive factor produced by human lung cancer cell line A549 on the production and action of interleukin 1.

Z H Feng1, G M Zhang, T L Hao, Z C Chen, Z Y Jiang.   

Abstract

A549, a human lung cancer cell line, spontaneously produces a tumor-derived immunosuppressive factor (TDSF) which inhibits the production and action of interleukin 1 (IL-1). After exposure of macrophages to TDSF for 5 h, the production of IL-1 by macrophages was significantly inhibited. The inhibition was much stronger if TDSF existed continuously in macrophage culture. The response of thymocytes treated with nylon wool to exogenous IL-1 was significantly suppressed in the presence of TDSF, suggesting that TDSF can inhibit the action of IL-1. The thymocytes untreated with nylon wool could proliferate after being stimulated with Con A. The proliferation was significantly suppressed by TDSF in a dose-dependent manner. These results suggest that the inhibitory action of TDSF on T cell activation is associated with IL-1, and that TDSF might exert an inhibitory action on other reactions mediated by IL-1. Furthermore, TDSF can reduce the supplementation of new T cells by inhibiting the proliferation of thymocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2255000     DOI: 10.1007/bf02986449

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  9 in total

1.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

2.  Biologic characteristics of an immunosuppressive factor derived from a human lung cancer cell line.

Authors:  R D Wang; Z C Chen; Y Luo; Z H Feng
Journal:  J Tongji Med Univ       Date:  1989

3.  Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.

Authors:  J Kaye; S Gillis; S B Mizel; E M Shevach; T R Malek; C A Dinarello; L B Lachman; C A Janeway
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

4.  Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells.

Authors:  J G Giri; P W Kincade; S B Mizel
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

5.  Human interleukin 1 is a cytocidal factor for several tumor cell lines.

Authors:  K Onozaki; K Matsushima; B B Aggarwal; J J Oppenheim
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

6.  Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.

Authors:  D N Sauder; N L Mounessa; S I Katz; C A Dinarello; J I Gallin
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

7.  The effects of interleukin 1 on human B cell activation and proliferation.

Authors:  R J Falkoff; A Muraguchi; J X Hong; J L Butler; C A Dinarello; A S Fauci
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

8.  Interleukin-1 stimulation of astroglial proliferation after brain injury.

Authors:  D Giulian; L B Lachman
Journal:  Science       Date:  1985-04-26       Impact factor: 47.728

9.  Effect of interleukin 1 on human thymocytes and purified human T cells.

Authors:  A L Maizel; S R Mehta; R J Ford; L B Lachman
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.